Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who are proficient in English
- People who have been diagnosed with lymphoma, leukemia, or myeloma
- People whose cancer is stable or shows no signs of active disease, as confirmed by their medical records or oncology team
- People who score below 54 on a specific memory and thinking self-assessment tool called the FACT-Cog PCI subscale (confirm with trial site)
- People whose doctor estimates they have a life expectancy of at least one year
- People who are able to complete all study assessments independently, without assistance
- People who are able to understand and sign an informed consent form written in English
Who may not be able to join:
- People who finished surgery, radiation, induction chemotherapy, transplantation, or certain immunotherapy treatments (such as CAR T-Cell or bispecific antibodies) less than 3 months ago — or, for ongoing continuous therapies, people who have been on that therapy for less than 6 months (note: maintenance therapies are generally allowed)
- People who have received music therapy in the past year
- People who are currently receiving music training, have had more than 6 months of music training in the past 10 years, or plan to start music training during the study
- People who do not have access to a device connected to the internet
- People who are currently experiencing active suicidal thoughts, or who have a diagnosis of bipolar disorder, schizophrenia, or a substance use disorder
- People who score 10 or higher on a cognitive screening tool that may indicate dementia (confirm with trial site)
- People who have vision, hearing, or movement difficulties that cannot be corrected
- People who have started or changed the dose of certain medications — such as sedatives, stimulants, or anti-cholinergic drugs — in the past month, or who plan to do so during the study, as these are known to affect thinking and memory
- People who have started any other treatment aimed at improving cancer-related thinking or memory difficulties in the past month, or who plan to do so during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kevin Liou, MD, Memorial Sloan Kettering Cancer Center
Phone: 646-608-8563
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors as defined as the completion of 9 or more sessions.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.